SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-059524
Filing Date
2024-05-14
Accepted
2024-05-14 16:06:42
Documents
15
Period of Report
2024-05-13
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20240513.htm   iXBRL 8-K 63728
2 EX-10.1 bolt-ex10_1.htm EX-10.1 68480
3 EX-10.2 bolt-ex10_2.htm EX-10.2 61356
4 EX-99.1 bolt-ex99_1.htm EX-99.1 233166
5 GRAPHIC img192637872_0.jpg GRAPHIC 3892
  Complete submission text file 0000950170-24-059524.txt   594604

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20240513.xsd EX-101.SCH 25968
18 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20240513_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 24944289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)